Zeil Rosenberg | Executive Vice President, Medical
Tonix Pharmaceuticals

Dr. Zeil Rosenberg is responsible for vaccine development at Tonix Pharmaceuticals. Previous to this, he was Therapeutic Area Head for Vaccines at PPD (AES) , Worldwide Business Leader for Vaccines at Becton Dickinson (BD), and resident National Immunization Advisor in Indonesia through USAID and the American Association for the Advancement of Science (AAAS) where he helped achieve the virtual elimination of maternal and  neonatal tetanus. He studied economics at Stanford, received his MD at UCSF and completed post-graduate medical training at Cornell.